Replies to post #253723 on Biotech Values

[DewDiligence]

Roche acquires PSTX for $9.00/sh cash+CVR—a 215% premium to yesterday’s closing price (excluding the value of the CVR):

https://finance.yahoo.com/news/poseida-therapeutics-inc-announces-agreement-061000051.html